Guidance for industry : S7B nonclinical evaluation of the potential for delayed ventricular repolarization (QT Interval Prolongation) by human pharmaceuticals.
| Other author/creator | Center for Drug Evaluation and Research (U.S.) |
| Other author/creator | Center for Biologics Evaluation and Research (U.S.) |
| Other author/creator | International Conference on Harmonisation. |
| Format | Electronic and Book |
| Publication Info | Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [2005] |
| Description | 10 p. : digital, PDF file |
| Supplemental Content | https://purl.fdlp.gov/GPO/LPS113878 |
| Subject(s) |
Click here for more information about this title
| Portion of title | S7B nonclinical evaluation of the potential for delayed ventricular repolarization (QT Interval Prolongation) by human pharmaceuticals |
| Portion of title | Nonclinical evaluation of the potential for delayed ventricular repolarization (QT Interval Prolongation) by human pharmaceuticals |
| General note | Title from PDF title page (viewed on June 19th, 2009). |
| General note | "ICH". |
| General note | "October 2005". |
| General note | GPO Cataloging Record Distribution Program (CRDP). |
| Technical details | Mode of access: Internet at the FDA web site. Address as of 6/18/09: http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm129122.pdf ; current access is available via PURL. |
| GPO item number | 0499-T (online) |
| Govt. docs number | HE 20.4702:N 73/2 |
Available Items
| Library | Location | Call Number | Status | Item Actions | |
| Joyner | Electronic Resources | Access Content Online | ✔ Available |